Would it be possible for small pharmas to conduct co-R&D?

Chairman Yong-Joon Jo(CEO/President of Dongkoo Bio&Pharma) at the Korea Pharmaceutical Ind. Coop., which currently has approximately 100 medium and small pharmaceutical companies as its member, said at an interview with a medium “Our members, medium and small pharmaceutical companies, are inevitably weaker than large pharmas in competition of scale. I believe medium and small companies should i...